181 related articles for article (PubMed ID: 2095753)
21. Disappearance of minimal residual lymphoblastic leukemia cells 6 months after allogeneic bone marrow transplantation without GVHD.
Kiyoi H; Naoe T; Kitamura K; Yamauchi T; Ichihashi T; Ohno R
Bone Marrow Transplant; 1991 Jul; 8(1):59-62. PubMed ID: 1912956
[TBL] [Abstract][Full Text] [Related]
22. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Wu N; Lu S; Zhu P; Liu L; Peng Y
Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
Barrett AJ; Horowitz MM; Pollock BH; Zhang MJ; Bortin MM; Buchanan GR; Camitta BM; Ochs J; Graham-Pole J; Rowlings PA
N Engl J Med; 1994 Nov; 331(19):1253-8. PubMed ID: 7935682
[TBL] [Abstract][Full Text] [Related]
24. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
[TBL] [Abstract][Full Text] [Related]
25. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.
Wasserman R; Galili N; Ito Y; Silber JH; Reichard BA; Shane S; Womer RB; Lange B; Rovera G
J Clin Oncol; 1992 Dec; 10(12):1879-88. PubMed ID: 1453203
[TBL] [Abstract][Full Text] [Related]
26. Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia.
Wasserman R; Felix CA; McKenzie SE; Shane S; Lange B; Finger LR
Leukemia; 1993 Aug; 7(8):1294-9. PubMed ID: 8350631
[TBL] [Abstract][Full Text] [Related]
27. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
Estrov Z; Grunberger T; Dubé ID; Wang YP; Freedman MH
N Engl J Med; 1986 Aug; 315(9):538-42. PubMed ID: 3488505
[TBL] [Abstract][Full Text] [Related]
28. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.
Scholten C; Födinger M; Mitterbauer M; Laczika K; Mitterbauer G; Haas OA; Knöbl P; Schwarzinger I; Thalhammer R; Purtscher B
Ann Hematol; 1995 Oct; 71(4):155-60. PubMed ID: 7578520
[TBL] [Abstract][Full Text] [Related]
30. [The clinical significance of detecting minimal residual disease in the bone marrow of patients with B-cell neoplasm].
Yu L; Sun Y; Liu J
Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):22-5. PubMed ID: 7600873
[TBL] [Abstract][Full Text] [Related]
31. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
[TBL] [Abstract][Full Text] [Related]
32. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia.
Goulden N; Langlands K; Steward C; Katz F; Potter M; Chessells J; Oakhill A
Br J Haematol; 1994 Jun; 87(2):282-5. PubMed ID: 7947268
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Willoughby M
Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
[TBL] [Abstract][Full Text] [Related]
34. Silence of the leukemic clone.
Greaves M
N Engl J Med; 1997 Jan; 336(5):367-9. PubMed ID: 9011792
[No Abstract] [Full Text] [Related]
35. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.
Yamada M; Hudson S; Tournay O; Bittenbender S; Shane SS; Lange B; Tsujimoto Y; Caton AJ; Rovera G
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5123-7. PubMed ID: 2500663
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
Ramírez M; Díaz MA; Madero L; Bueren JA
Leuk Res; 2003 Dec; 27(12):1153-7. PubMed ID: 12921954
[TBL] [Abstract][Full Text] [Related]
37. [Detection of residual tumor cells in the bone marrow of children with B-linear acute lymphoblastic leukemia by flow cytofluorometry].
Belevtsev MB; Savitskiĭ VP; Savva NN; Petina OV; Migal' NV; Aleĭnikova OV
Klin Lab Diagn; 2006 Oct; (10):42-6. PubMed ID: 17144545
[No Abstract] [Full Text] [Related]
38. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
[TBL] [Abstract][Full Text] [Related]
39. Ratio of methotrexate to folate uptake by lymphoblasts in children with B-lineage acute lymphoblastic leukemia: a pilot study.
Mantadakis E; Smith AK; Kamen BA
J Pediatr Hematol Oncol; 2000; 22(3):221-6. PubMed ID: 10864053
[TBL] [Abstract][Full Text] [Related]
40. Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction.
Brisco MJ; Condon J; Sykes PJ; Neoh SH; Morley AA
Br J Haematol; 1991 Oct; 79(2):211-7. PubMed ID: 1958478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
